Search Results - "Janssen, J A M L"

Refine Results
  1. 1
  2. 2

    Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes by Janssen, Joseph A M J L

    “…The worldwide incidence of prediabetes/type 2 has continued to rise the last 40 years. In the same period, the mean daily energy intake has increased, and the…”
    Get full text
    Journal Article
  3. 3

    An early diagnostic tool for diabetic peripheral neuropathy in rats by Kambiz, Shoista, van Neck, Johan W, Cosgun, Saniye G, van Velzen, Marit H N, Janssen, Joop A M J L, Avazverdi, Naim, Hovius, Steven E R, Walbeehm, Erik T

    Published in PloS one (18-05-2015)
    “…The skin's rewarming rate of diabetic patients is used as a diagnostic tool for early diagnosis of diabetic neuropathy. At present, the relationship between…”
    Get full text
    Journal Article
  4. 4

    Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly by Varewijck, A. J., Janssen, J. A. M. J. L., Vähätalo, M., Hofland, L. J., Lamberts, S. W. J., Yki-Järvinen, H.

    Published in Diabetologia (01-04-2012)
    “…Aims/hypothesis The aim of this study was to compare IGF-I bioactivity 36 weeks after the addition of insulin glargine (A21Gly,B31Arg,B32Arg human insulin) or…”
    Get full text
    Journal Article
  5. 5

    The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change by Janssen, Joseph A M J L

    “…The metabolic syndrome is a cluster of overlapping conditions resulting in an increased incidence of type 2 diabetes, cardiovascular disease, and cancer. In…”
    Get full text
    Journal Article
  6. 6
  7. 7

    How to Position Pasireotide LAR Treatment in Acromegaly by Coopmans, Eva C, Muhammad, Ammar, van der Lely, Aart J, Janssen, Joseph A M J L, Neggers, Sebastian J C M M

    “…Abstract Context Pasireotide long-acting release (LAR) is a somatostatin multireceptor ligand, and in the current consensus criteria pasireotide LAR is…”
    Get full text
    Journal Article
  8. 8

    Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression by Muhammad, Ammar, Coopmans, Eva C, Gatto, Federico, Franck, Sanne E, Janssen, Joseph A M J L, van der Lely, Aart Jan, Hofland, Leo J, Neggers, Sebastian J C M M

    “…The response to first-generation somatostatin receptor ligands (SRLs) treatment in acromegaly correlates with expression of somatostatin receptor subtype 2…”
    Get full text
    Journal Article
  9. 9

    The Introduction of the IDS-iSYS Total IGF-1 Assay May Have Far-Reaching Consequences for Diagnosis and Treatment of GH Deficiency by Varewijck, A. J, Lamberts, S. W. J, van der Lely, A. J, Neggers, S. J. C. M. M, Hofland, L. J, Janssen, J. A. M. J. L

    “…Context: IGF-1 measurements are used for screening and monitoring GH deficiency (GHD) and acromegaly. Objective: Our objective was to study whether the…”
    Get full text
    Journal Article
  10. 10

    Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions by Gauna, Carlotta, Kiewiet, Rosalie M, Janssen, Joop A M J L, van de Zande, Bedette, Delhanty, Patric J D, Ghigo, Ezio, Hofland, Leo J, Themmen, Axel P N, van der Lely, Aart Jan

    “…Acylated and unacylated ghrelin (AG and UAG) are gut hormones that exert pleiotropic actions, including regulation of insulin secretion and glucose metabolism…”
    Get more information
    Journal Article
  11. 11

    Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer by Janssen, Joseph A. M. J. L.

    “…For many years, the dogma has been that insulin resistance precedes the development of hyperinsulinemia. However, recent data suggest a reverse order and place…”
    Get full text
    Journal Article
  12. 12

    Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy by Smith, Terry J, Janssen, Joseph A M J L

    Published in Endocrine reviews (01-02-2019)
    “…Abstract Thyroid-associated ophthalmopathy (TAO) is a complex disease process presumed to emerge from autoimmunity occurring in the thyroid gland, most…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Soluble Klotho: a possible predictor of quality of life in acromegaly patients by Coopmans, Eva C., El-Sayed, Nour, Frystyk, Jan, Magnusson, Nils E., Jørgensen, Jens O. L., van der Lely, Aart-Jan, Janssen, Joop A. M. J. L., Muhammad, Ammar, Neggers, Sebastian J. C. M. M.

    Published in Endocrine (01-07-2020)
    “…Purpose Although quality of life (QoL) is improved in patients with acromegaly after disease control, QoL correlates only weakly with traditional biomarkers…”
    Get full text
    Journal Article
  15. 15

    Ghrelin Stimulates, Whereas Des-Octanoyl Ghrelin Inhibits, Glucose Output by Primary Hepatocytes by Gauna, Carlotta, Delhanty, Patric J. D., Hofland, Leo J., Janssen, Joop A. M. J. L., Broglio, Fabio, Ross, Richard J. M., Ghigo, Ezio, van der Lely, Aart Jan

    “…Ghrelin exerts various metabolic activities, including regulation of glucose levels in humans. To verify whether the glucose response to ghrelin reflects a…”
    Get full text
    Journal Article
  16. 16

    Endogenous Hormones and Carotid Atherosclerosis in Elderly Men by van den Beld, A. W., Bots, M. L., Janssen, J. A. M. L. L., Pols, H. A. P., Lamberts, S. W. J., Grobbee, D. E.

    Published in American journal of epidemiology (01-01-2003)
    “…The aging process is characterized by a number of gradual changes in circulating hormone concentrations as well as a gradual increase in the degree of…”
    Get full text
    Journal Article
  17. 17

    Circulating IgGs May Modulate IGF-I Receptor Stimulating Activity in a Subset of Patients With Graves' Ophthalmopathy by Varewijck, Aimee J, Boelen, Anita, Lamberts, Steven W. J, Fliers, Eric, Hofland, Leo J, Wiersinga, Wilmar M, Janssen, Joseph A. M. J. L

    “…Context: There is a close association between levels of TSH binding inhibitory immunoglobulins (TBIIs) and Graves' ophthalmopathy (GO). In addition to the TSH…”
    Get full text
    Journal Article
  18. 18

    New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome by Janssen, Joseph A. M. J. L.

    “…Recent data suggests that (pre)diabetes onset is preceded by a period of hyperinsulinemia. Consumption of the “modern” Western diet, over-nutrition, genetic…”
    Get full text
    Journal Article
  19. 19

    Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations by Janssen, Joseph A M J L, Hofland, Leo J, Strasburger, Christian J, van den Dungen, Elisabeth S R, Thevis, Mario

    Published in PloS one (18-03-2016)
    “…To compare full-length mechano growth factor (full-length MGF) with human recombinant insulin-like growth factor-I (IGF-I) and human recombinant insulin (HI)…”
    Get full text
    Journal Article
  20. 20

    A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height by Rietveld, I., Janssen, J. A. M. J. L., Van Rossum, E. F. C., Houwing-Duistermaat, J. J., Rivadeneira, F., Hofman, A., Pols, H. A. P., Van Duijn, C. M., Lamberts, S. W. J.

    Published in Clinical endocrinology (Oxford) (01-08-2004)
    “…Summary objective  A polymorphism near the promoter region of the IGF‐I gene has been associated with serum IGF‐I levels, age‐related decline of serum IGF‐I…”
    Get full text
    Journal Article